A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated...

More than 100,000 people across England have tested themselves for SARS-CoV-2 antibodies at home as part of a major research programme Led by Imperial College London, the REACT (REal Time Assessment of...